US loss of exclusivity · Oncology

Imfinzi

AstraZeneca

2031US biosimilars from
2025Today: 20262037
2025 worldwide sales
$6.1B
Date basis
Company guidance
US biosimilars
Early development
Pharma Patent Cliff by readouts.io Data checked 24 October 2026 · Full Imfinzi timeline →